Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis
Background: The aim of this study was to identify novel microRNAs for potential use in the diagnosis of pancreatic cancer (PaC). Methods: A total of 1063 serum samples from 303 patients with PaC were collected, and the expression level of miR-25 was measured using quantitative real-time PCR (qRT-PCR...
Main Authors: | Ting Deng, Yaozong Yuan, Chunni Zhang, Chenyu Zhang, Weiyan Yao, Cheng Wang, Rui Liu, Yi Ba |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2016-09-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | http://www.karger.com/Article/FullText/447872 |
Similar Items
-
Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure
by: Junjie Xiao, et al.
Published: (2017-02-01) -
Distinct Response of Circulating microRNAs to the Treatment of Pancreatic Cancer Xenografts with FGFR and ALK Kinase Inhibitors
by: Ivana Peran, et al.
Published: (2022-03-01) -
MiR-3168, miR-6125, and miR-4718 as potential predictors of cisplatin-induced nephrotoxicity in patients with head and neck cancer
by: Julia C. F. Quintanilha, et al.
Published: (2021-05-01) -
The Predictive Value of miR-16, -29a and -134 for Early Identification of Gestational Diabetes: A Nested Analysis of the DALI Cohort
by: Anja Elaine Sørensen, et al.
Published: (2021-01-01) -
Circulating levels of inflammation-associated miR-155 and endothelial-enriched miR-126 in patients with end-stage renal disease
by: Honglei Wang, et al.
Published: (2012-12-01)